Charles Parker
Royal Marsden NHS Foundation Trust(GB)Institute of Cancer Research(GB)University of Utah(US)London Cancer(GB)University College London(GB)
Publications by Year
Research Areas
Porphyrin Metabolism and Disorders, Neonatal Health and Biochemistry, Heme Oxygenase-1 and Carbon Monoxide, Complement system in diseases, Prostate Cancer Treatment and Research
Most-Cited Works
- → Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria(2020)572 cited
- → The Lancet Commission on prostate cancer: planning for the surge in cases(2024)549 cited
- → Afamelanotide for Erythropoietic Protoporphyria(2015)271 cited
- → Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent Porphyria(2019)252 cited
- → EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks(2019)165 cited
- → Eculizumab for paroxysmal nocturnal haemoglobinuria(2009)163 cited